Sign in

CIK 0001368514

  • Large accelerated filer

ADMA BIOLOGICS, INC.

Sign in to watch
Ticker
ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562590442
Phone
+1 201-478-5552
Business address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
Former names
R&R ACQUISITION VI, INC
  1. 4 Open-market buy Director bought 20,000 shares at $4.78 ($95,600)
  2. 4 Open-market buy VP, CFO bought 5,000 shares at $4.78 ($23,900)
  3. 4 Open-market buy Director bought 5,230 shares at $4.78 ($24,999)
  4. 4 Open-market sale 10% owner sold 8,591,160 shares
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4/A Open-market buy Director bought 5,813,954 shares at $2.15 ($12,500,001)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market buy Director bought 5,813,954 shares at $2.15 ($12,500,001)
  11. 4 Open-market buy Director bought 25,000 shares at $2.15 ($53,750)
  12. 4 Open-market buy VP, CFO bought 6,500 shares at $2.15 ($13,975)
  13. 4 Open-market buy President and CEO bought 485,000 shares at $2.15 ($1,042,750)
  14. 4 Open-market buy EVP, CSO and CMO bought 10,000 shares at $2.15 ($21,500)
  15. 4 Option exercise President and CEO acquired 42,021 shares (option exercise)
  16. 4 Option exercise Director acquired 48,185 shares (option exercise)
  17. 4 Option exercise Director acquired 2,800 shares (option exercise)
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 4 Derivatives Options or other derivatives

Page 12 of 19 · 364 filings